Diarrhea clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

    Sorry, in progress, not accepting new patients

    This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment. Monoclonal antibodies, such as isatuximab, may interfere with the ability of cancer cells to grow and spread.

    at UC Davis UC Irvine

  • PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.

    at UCLA

Last updated: